Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Malaria

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 68 articles: HTML format

Single Articles

September 2025
1. DE ALBUQUERQUE NRM, Corder RM, Johansen IC, Ladeia WA, et al
   The source-sink dynamics of Plasmodium vivax may undermine malaria elimination efforts in the Amazon: an epidemiological and population genomic study.
   J Infect Dis. 2025 Sep 4:jiaf457. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2025
2. JATT LP, Gillespie KM, Van P, Hoffman SL, et al
   Manuscript title: Cytokines Associated With Moderate and Severe Adverse Events During a Sporozoite Malaria Vaccine Trial with Controlled Human Malaria Infection.
   J Infect Dis. 2025 Aug 14:jiaf435. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. CHUANG YM, Ledizet M, Mattessich M, Fikrig E, et al
   A multivalent peptide vaccine against malaria, targeting Plasmodium CSP and mosquito AgTRIO.
   J Infect Dis. 2025 Aug 13:jiaf432. doi: 10.1093.
   PubMed     Abstract available
   
   
   July 2025
4. SAEED M, Aitken EH, Naung MT, Bourke C, et al
   Association of a novel IgG3 allele with malaria in children from the Sepik region of Papua New Guinea.
   J Infect Dis. 2025 Jul 25:jiaf390. doi: 10.1093.
   PubMed     Abstract available
   
   
   June 2025
5. SSUUNA C, Mishra H, Hawkes MT, Stefanova V, et al
   Elevated suPAR levels, organ dysfunction and death in children hospitalized with malaria: considerations for use as a risk stratification tool.
   J Infect Dis. 2025 Jun 17:jiaf327. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. BERTRAN-COBO C, Dumont E, Noordin NR, Lai MY, et al
   Plasmodium knowlesi Infection Is Associated With Elevated Circulating Biomarkers of Brain Injury and Endothelial Activation.
   J Infect Dis. 2025;231:e966-e975.
   PubMed     Abstract available
   
   
   
7. SLAUGHTER MG, Bhumbra S, Mellencamp KA, Namazzi R, et al
   Elevated Levels of PDGF-BB and VEGF Are Associated With a Decreased Risk of Readmission or Death in Children With Severe Malarial Anemia.
   J Infect Dis. 2025;231:1258-1266.
   PubMed     Abstract available
   
   
   May 2025
8. COPELAND NK, Otieno L, Otieno JD, Otieno S, et al
   Efficacy of RTS,S/AS01E only seen in baseline parasitemic and not baseline aparasitemic Plasmodium falciparum-exposed, drug-treated Kenyan adults.
   J Infect Dis. 2025 May 29:jiaf274. doi: 10.1093.
   PubMed     Abstract available
   
   
   
9. SARR D, Andrew AK, Shukla AK, Mwalimu S, et al
   Placental Malaria Induces Oxidative Stress in Human Syncytiotrophoblast.
   J Infect Dis. 2025 May 14:jiaf243. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2025
10. MARTIN AC, Sadler JM, Simkin A, Musonda M, et al
    Emergence and Rising Prevalence of Artemisinin Partial Resistance Marker Kelch13 P441L in a Low Malaria Transmission Setting in Southern Zambia.
    J Infect Dis. 2025 Apr 17:jiaf188. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. DIEPPOIS C, Adjemout M, Cretin J, Gallardo F, et al
    An Expression Quantitative Trait Locus of Fc Gamma Receptor Genes Is Associated With Antimalarial IgG Responses and Infection Levels in Burkinabe Families.
    J Infect Dis. 2025;231:1008-1019.
    PubMed     Abstract available
    
    
    March 2025
12. FANCONY C, Fortes-Gabriel E, Zage F, Alexiou E, et al
    Artemether-Lumefantrine treatment selects Plasmodium falciparum multidrug resistance 1 (pfmdr1) increased copy number among African malaria infections.
    J Infect Dis. 2025 Mar 26:jiaf155. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. GOSWAMI R, Manickam Y, Goel JC, Gupta S, et al
    Chemical targeting of prolyl-tRNA synthetase stalls ovarian development and kills malaria vectors.
    J Infect Dis. 2025 Mar 6:jiaf095. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2025
14. NAMAZZI R, Kazinga C, Lima-Cooper G, Liepmann C, et al
    G6PD deficiency is associated with an increased risk of acute kidney injury independent of hemolytic complications in children with severe malaria.
    J Infect Dis. 2025 Feb 18:jiaf080. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. SCHALLENBERG E, van Loon W, Mbarushimana D, Igiraneza C, et al
    Prevalence of Plasmodium falciparum drug resistance markers pfcrt K76T and pfaat1 S258L in southern Rwanda, 2010 to 2023.
    J Infect Dis. 2025 Feb 12:jiaf068. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. SANCHEZ JF, Valdivia HO, Pannebaker DL
    Malaria Surveillance: A Cross-sectional Study in the Peruvian Amazon Basin, 2012-2023.
    J Infect Dis. 2025;231.
    PubMed     Abstract available
    
    
    
17. TAPIA LL, Salas CJ, Sanchez JF, Pannebaker DL, et al
    U.S. NAMRU SOUTH's Insights and Contributions to Diagnostics in the Context of Malaria Elimination.
    J Infect Dis. 2025;231.
    PubMed     Abstract available
    
    
    
18. WERNSMAN YOUNG N, Gashema P, Giesbrecht D, Munyaneza T, et al
    High Frequency of Artemisinin Partial Resistance Mutations in the Great Lakes Region Revealed Through Rapid Pooled Deep Sequencing.
    J Infect Dis. 2025;231:269-280.
    PubMed     Abstract available
    
    
    
19. KARIUKI SN, Gilchrist JJ, Uyoga S, Macharia A, et al
    Relation Between the Dantu Blood Group Variant and Bacteremia in Kenyan Children: A Population-Based Case-Control Study.
    J Infect Dis. 2025;231:e10-e16.
    PubMed     Abstract available
    
    
    December 2024
20. MARTIN AC, Chaponda M, Muleba M, Lupiya J, et al
    Impact of late rainy season indoor residual spraying on holoendemic malaria transmission: a cohort study in northern Zambia.
    J Infect Dis. 2024 Dec 19:jiae609. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. KAMALIDDIN C, Burke-Gaffney J, Ashraf S, Castaneda-Mogollon D, et al
    A Countrywide Survey of hrp2/3 Deletions and kelch13 Mutations Co-occurrence in Ethiopia.
    J Infect Dis. 2024;230:e1394-e1401.
    PubMed     Abstract available
    
    
    
22. HAGENAH LM, Yeo T, Schindler KA, Jeon JH, et al
    Plasmodium falciparum African PfCRT Mutant Isoforms Conducive to Piperaquine Resistance are Infrequent and Impart a Major Fitness Cost.
    J Infect Dis. 2024 Dec 11:jiae617. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2024
23. LOPEZ-PEREZ M, Viwami F, Ampomah P, Sustic T, et al
    Fc-Afucosylation of VAR2CSA-Specific Immunoglobulin G and Clinical Immunity to Placental Plasmodium falciparum Malaria.
    J Infect Dis. 2024 Nov 25:jiae529. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2024
24. LAPIDUS S, Goheen MM, Sy M, Deme AB, et al
    Two mosquito salivary antigens demonstrate promise as biomarkers of recent exposure to P. falciparum infected mosquito bites.
    J Infect Dis. 2024 Oct 30:jiae525. doi: 10.1093.
    PubMed     Abstract available
    
    
    
25. PESTANA K, Ford A, Rama R, Abagero B, et al
    Copy Number Variations of Plasmodium vivax DBP1, EBP/DBP2, and RBP2b in Ethiopians Who Are Duffy Positive and Duffy Negative.
    J Infect Dis. 2024;230:1004-1012.
    PubMed     Abstract available
    
    
    
26. RATHNAM JTT, Grigg MJ, Dondorp AM, William T, et al
    Reduced red blood cell deformability in vivax malaria.
    J Infect Dis. 2024 Oct 7:jiae490. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2024
27. TAY MZ, Tang W, Lee WC, Ong ASM, et al
    Functional and Immunologic Mapping of Domains of the Reticulocyte-Binding Protein Plasmodium vivax PvRBP2a.
    J Infect Dis. 2024;230:e737-e742.
    PubMed     Abstract available
    
    
    August 2024
28. NAMAZZI R, Mellencamp KA, Opoka RO, Datta D, et al
    Circulating immune complexes and G6PD deficiency predict readmissions for blackwater fever and severe anemia in children with severe malaria in Eastern Uganda.
    J Infect Dis. 2024 Aug 29:jiae431. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. LAURY JE, Mugittu K, Kajeguka DC, Kamugisha E, et al
    Efficacy and safety of artemether-lumefantrine against uncomplicated falciparum malaria infection in Tanzania, 2022, a single arm clinical trial.
    J Infect Dis. 2024 Aug 26:jiae425. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. TUKWASIBWE S, Garg S, Katairo T, Asua V, et al
    Varied Prevalence of Antimalarial Drug Resistance Markers in Different Populations of Newly Arrived Refugees in Uganda.
    J Infect Dis. 2024;230:497-504.
    PubMed     Abstract available
    
    
    
31. LEE H, Choi Y, Park S
    Obesity, diabetes, Plasmodium infection, and severe malaria in adults: A systematic review and meta-analysis.
    J Infect Dis. 2024 Aug 1:jiae377. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2024
32. BERNA AZ, Wang XR, Bollinger LB, Banda J, et al
    Breath biomarkers of pediatric malaria: reproducibility and response to antimalarial therapy.
    J Infect Dis. 2024 Jun 17:jiae323. doi: 10.1093.
    PubMed     Abstract available
    
    
    
33. JOOF F, Hu R, Saidi A, Seydel KB, et al
    Plasma from older children in Malawi inhibits Plasmodium falciparum binding in 3D brain microvessels.
    J Infect Dis. 2024 Jun 14:jiae315. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2024
34. RAPP T, Amagai K, Sinai C, Basham C, et al
    Micro-heterogeneity of transmission shapes submicroscopic malaria carriage in coastal Tanzania.
    J Infect Dis. 2024 May 23:jiae276. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. ALI NA, Nema S, Schneider KA, Krishna S, et al
    Low Prevalence of Antimalarial Resistance Mutations in India During 2014-2015: Impact of Combining First-line Therapy With Primaquine.
    J Infect Dis. 2024;229:1574-1583.
    PubMed     Abstract available
    
    
    
36. PERSSON KEM, Horton JL, Kurtovic L, McCarthy JS, et al
    Declining antibody affinity over time after human vaccination with a Plasmodium falciparum merozoite vaccine candidate.
    J Infect Dis. 2024 May 9:jiae259. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2024
37. GRAUMANS W, Ayo D, van Lieshout N, Lanke K, et al
    Plasmodium malariae and Plasmodium ovale-Prevalent and Relevant.
    J Infect Dis. 2024;229:1239-1240.
    PubMed    
    
    
    March 2024
38. ADJEMOUT M, Gallardo F, Torres M, Thiam A, et al
    From GWAS to functional variants: ARL14 cis-regulatory variants are associated with severe malaria.
    J Infect Dis. 2024 Mar 26:jiae159. doi: 10.1093.
    PubMed     Abstract available
    
    
    
39. WESTERCAMP N, Osei-Tutu L, Schuerman L, Kariuki SK, et al
    Could less be more? Accounting for fractional-dose regimens and different number of vaccine doses when measuring the impact of the RTS, S/AS01E malaria vaccine.
    J Infect Dis. 2024 Mar 4:jiae075. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2024
40. CAO Y, Hayashi CTH, Kumar N
    A novel ex vivo assay to evaluate functional effectiveness of Plasmodium vivax transmission blocking vaccine using Pvs25 transgenic P. berghei.
    J Infect Dis. 2024 Feb 26:jiae102. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. PRAH DA, Laryea-Akrong E
    Asymptomatic Low-Density Plasmodium falciparum Infections: Parasites Under the Host's Immune Radar?
    J Infect Dis. 2024 Feb 13:jiad581. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. FRIEDMAN-KLABANOFF DJ, Berry AA, Travassos MA, Shriver M, et al
    Recombinant full-length Plasmodium falciparum circumsporozoite protein-based vaccine adjuvanted with GLA-LSQ: Results of Phase 1 testing with malaria challenge.
    J Infect Dis. 2024 Feb 8:jiae062. doi: 10.1093.
    PubMed     Abstract available
    
    
    
43. FONTOURA PS, Macedo EG, Calil PR, Corder RM, et al
    Changing Clinical Epidemiology of Plasmodium vivax Malaria as Transmission Decreases: Population-Based Prospective Panel Survey in the Brazilian Amazon.
    J Infect Dis. 2024 Feb 7:jiad456. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2024
44. SCHWAKE CJ, Krueger RM, Hanada T, Chishti AH, et al
    Plasmodium falciparum glutamic acid-rich protein (PfGARP)-independent polyclonal antibodies inhibit malaria parasite growth in human erythrocytes.
    J Infect Dis. 2024 Jan 31:jiae050. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. SILVA NI, Souza PFL, Silva BF, Fonseca SG, et al
    Host transcriptional meta-signatures reveal diagnostic biomarkers for Plasmodium falciparum malaria.
    J Infect Dis. 2024 Jan 25:jiae041. doi: 10.1093.
    PubMed     Abstract available
    
    
    
46. OLEINIKOV AV, Seidu Z, Oleinikov IV, Tetteh M, et al
    Profiling the Plasmodium falciparum Erythrocyte Membrane Protein 1-Specific Immununoglobulin G Response Among Ghanaian Children With Hemoglobin S and C.
    J Infect Dis. 2024;229:203-213.
    PubMed     Abstract available
    
    
    December 2023
47. MUFUMBA I, Kazinga C, Namazzi R, Opoka RO, et al
    sTREM-1: a biomarker of mortality in severe malaria impacted by acute kidney injury.
    J Infect Dis. 2023 Dec 11:jiad561. doi: 10.1093.
    PubMed     Abstract available
    
    
    
48. BARO B, Bassat Q
    sTREM-1 to risk-stratify patients with malaria: A functional crystal ball to improve outcomes and save lifes.
    J Infect Dis. 2023 Dec 11:jiad565. doi: 10.1093.
    PubMed    
    
    
    
49. MALLA P, Wang Z, Brashear A, Yang Z, et al
    Effectiveness of unsupervised primaquine regimen for preventing Plasmodium vivax malaria relapses in northeast Myanmar, a single-arm non-randomized observational study.
    J Infect Dis. 2023 Dec 2:jiad552. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2023
50. POPKIN HALL ZR, Seth MD, Madebe RA, Budodo R, et al
    Malaria species positivity rates among symptomatic individuals across regions of differing transmission intensities in Mainland Tanzania.
    J Infect Dis. 2023 Nov 22:jiad522. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. ZAYET S, Hagenkotter B, Quadrio I, Gendrin V, et al
    Correspondence on 'Neurofilament light chain as a biomarker of neuronal damage in children with malaria'.
    J Infect Dis. 2023 Nov 9:jiad489. doi: 10.1093.
    PubMed    
    
    
    
52. THONGPOON S, Roobsoong W, Nguitragool W, Chotirat S, et al
    Naturally acquired transmission-blocking immunity against different strains of Plasmodium vivax in a malaria endemic area in Thailand.
    J Infect Dis. 2023 Nov 7:jiad469. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2023
53. JAIROCE C, Macia D, Torres-Yaguana JP, Mayer L, et al
    RTS, S/AS02A malaria vaccine-induced IgG responses equally recognize native-like fucosylated and non-fucosylated Plasmodium falciparum circumsporozoite proteins.
    J Infect Dis. 2023 Oct 27:jiad471. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. JOSTE V, Colard-Itte E, Guillochon E, Ariey F, et al
    Genetic Profiling of Plasmodium ovale wallikeri Relapses With Microsatellite Markers and Whole-Genome Sequencing.
    J Infect Dis. 2023;228:1089-1098.
    PubMed     Abstract available
    
    
    September 2023
55. ZENO EE, Obala AA, Pence B, Freedman E, et al
    Risk of malaria following untreated sub-patent Plasmodium falciparum infections: Results over 4 years from a cohort in a high transmission area in Western Kenya.
    J Infect Dis. 2023 Sep 15:jiad398. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. TRAORE K, Coulibaly D, Kone AK, Guindo B, et al
    Randomized field trial to assess the safety and efficacy of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in school-aged children in Bandiagara, Mali.
    J Infect Dis. 2023 Sep 8:jiad387. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2023
57. BALANZA N, Francis CK, Crowley VM, Weckman AM, et al
    Neurofilament light chain as a biomarker of neuronal damage in children with malaria.
    J Infect Dis. 2023 Aug 30:jiad373. doi: 10.1093.
    PubMed     Abstract available
    
    
    
58. XU E, Goel V, Baguma E, Ayebare E, et al
    Evolution of spatial risk of malaria infection after a pragmatic chemoprevention program in response to severe flooding in rural western Uganda.
    J Infect Dis. 2023 Aug 16:jiad348. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. NALWOGA A, Sabourin KR, Miley W, Jackson C, et al
    Plasmodium falciparum malaria is associated with increased KSHV seropositivity and higher KSHV antibody breadth and magnitude: results of a case-control study from rural Uganda.
    J Infect Dis. 2023 Aug 4:jiad308. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2023
60. SAMAYOA-REYES G, Weigel C, Koech E, Waomba K, et al
    Effect of Malaria Infection on Epstein-Barr Virus Persistence in Kenyan Children.
    J Infect Dis. 2023 Jul 11:jiad264. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2023
61. BARUA P, Duffy MF, Manning L, Laman M, et al
    Antibody to Plasmodium falciparum variant surface antigens, var gene transcription and ABO blood group in children with severe or uncomplicated malaria.
    J Infect Dis. 2023 Jun 21:jiad217. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2023
62. ROH ME, Zongo I, Haro A, Huang L, et al
    Seasonal malaria chemoprevention drug levels and drug resistance markers in children with or without malaria in Burkina Faso: a case control study.
    J Infect Dis. 2023 May 23:jiad172. doi: 10.1093.
    PubMed     Abstract available
    
    
    
63. SIBLEY CH
    A Breakthrough: Defining Plasmodium vivax Drug Resistance Genes.
    J Infect Dis. 2023;227:1119-1120.
    PubMed    
    
    
    April 2023
64. NZIZA N, Tran TM, DeRiso EA, Dolatshahi S, et al
    Accumulation of Neutrophil Phagocytic Antibody Features Tracks With Naturally Acquired Immunity Against Malaria in Children.
    J Infect Dis. 2023 Apr 26:jiad115. doi: 10.1093.
    PubMed     Abstract available
    
    
    
65. CHALLENGER JD, van Beek SW, Ter Heine R, van der Boor SC, et al
    Modelling the impact of a highly potent Plasmodium falciparum transmission-blocking monoclonal antibody in areas of seasonal malaria transmission.
    J Infect Dis. 2023 Apr 12:jiad101. doi: 10.1093.
    PubMed     Abstract available
    
    
    
66. ALEMNJI G, Mosha F, Maggiore P, Alexander H, et al
    Building Integrated Testing Programs for Infectious Diseases.
    J Infect Dis. 2023 Apr 12:jiad103. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2023
67. BHARDWAJ J, Upadhye A, Gaskin EL, Doumbo S, et al
    Neither the African-centric S47 nor P72 variant of TP53 is associated with reduced risk of febrile malaria in a Malian cohort study.
    J Infect Dis. 2023 Mar 24:jiad066. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2023
68. ANABIRE NG, Quintana MDP, Ofori MF, Hviid L, et al
    The rapid and spontaneous post-partum clearance of Plasmodium falciparum is related to expulsion of the placenta.
    J Infect Dis. 2023 Feb 6:jiad031. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malaria is free of charge.